{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:36:42Z","timestamp":1792132602853,"version":"4.4.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,13]]},"DOI":"10.7759\/cureus.27969","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T16:56:41Z","timestamp":1660409801000},"source":"Crossref","is-referenced-by-count":11,"title":["Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart"],"prefix":"10.7759","author":[{"given":"Revanth","family":"Kalluru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Gadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chikatimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejaswi","family":"Dasaradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jancy","family":"Koneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi priya","family":"Cherukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gcb.2010.03.007","article-title":"Cirrhosis: what else?","volume":"34","author":"Balabaud C","year":"2010","unstructured":"Balabaud C, Bioulac-Sage P. Cirrhosis: what else?. Gastroenterol Clin Biol. 2010, 34:252-254. 10.1016\/j.gcb.2010.03.007","journal-title":"Gastroenterol Clin Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan D","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008, 371:838-851. 10.1016\/S0140-6736(08)60383-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano R","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, et al.. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2095-2128. 10.1016\/S0140-6736(12)61728-0","journal-title":"Lancet"},{"key":"ref4","article-title":"Deaths: preliminary data for 2011","volume":"61","author":"Hoyert DL","year":"2012","unstructured":"Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012, 61:1-51.","journal-title":"Natl Vital Stat Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis EA","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014, 383:1749-1761. 10.1016\/S0140-6736(14)60121-5","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou WC","year":"2014","unstructured":"Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014, 20:7312-7324. 10.3748\/wjg.v20.i23.7312","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag A","year":"2010","unstructured":"Krag A, Bendtsen F, Henriksen JH, M\u00f8ller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010, 59:105-110. 10.1136\/gut.2009.180570","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh RN","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973, 60:646-649. 10.1002\/bjs.1800600817","journal-title":"Br J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez-Roisin R","year":"2004","unstructured":"Rodr\u00edguez-Roisin R, Krowka MJ, Herv\u00e9 P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004, 24:861-880. 10.1183\/09031936.04.00010904","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner R","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, et al.. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003, 124:91-96. 10.1053\/gast.2003.50016","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival in patients with Laennec\u2019s cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease","volume":"44","author":"Powell Jr WJ","year":"1968","unstructured":"Powell Jr WJ, Klatskin G. Duration of survival in patients with Laennec\u2019s cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med. 1968, 44:406-420. 10.1016\/0002-9343(68)90111-3","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01219.x","article-title":"High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients","volume":"24","author":"Saner FH","year":"2011","unstructured":"Saner FH, Neumann T, Canbay A, et al.. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011, 24:425-432. 10.1111\/j.1432-2277.2011.01219.x","journal-title":"Transpl Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000323","article-title":"High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis","volume":"49","author":"Wehmeyer MH","year":"2015","unstructured":"Wehmeyer MH, Heuer AJ, Benten D, P\u00fcschel K, Sydow K, Lohse AW, L\u00fcth S. High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis. J Clin Gastroenterol. 2015, 49:866-872. 10.1097\/MCG.0000000000000323","journal-title":"J Clin Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02468.x","article-title":"Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging","volume":"31","author":"Kazankov K","year":"2011","unstructured":"Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, Vilstrup H. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011, 31:534-540. 10.1111\/j.1478-3231.2011.02468.x","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Nazar A","year":"2013","unstructured":"Nazar A, Guevara M, Sitges M, et al.. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol. 2013, 58:51-57. 10.1016\/j.jhep.2012.08.027","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul M","year":"2014","unstructured":"Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014, 8:308-315. 10.1007\/s12072-014-9531-y","journal-title":"Hepatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.107.5.1467","article-title":"High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting","volume":"107","author":"Braverman AC","year":"1995","unstructured":"Braverman AC, Steiner MA, Picus D, White H. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest. 1995, 107:1467-1469. 10.1378\/chest.107.5.1467","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318198d734","article-title":"Prediction of cardiac complications after liver transplantation","volume":"87","author":"Fouad TR","year":"2009","unstructured":"Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation. 2009, 87:763-770. 10.1097\/TP.0b013e318198d734","journal-title":"Transplantation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos A","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019, 7:87-97. 10.1016\/j.jchf.2018.10.007","journal-title":"JACC Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000101573.54295.bd","article-title":"Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases","volume":"82","author":"Henrion J","year":"2003","unstructured":"Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003, 82:392-406. 10.1097\/01.md.0000101573.54295.bd","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-014-0206-8","article-title":"Cardiohepatic syndrome: liver injury in decompensated heart failure","volume":"11","author":"Laribi S","year":"2014","unstructured":"Laribi S, Mebazaa A. Cardiohepatic syndrome: liver injury in decompensated heart failure. Curr Heart Fail Rep. 2014, 11:236-240. 10.1007\/s11897-014-0206-8","journal-title":"Curr Heart Fail Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller S","year":"2013","unstructured":"M\u00f8ller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013, 34:2804-2811. 10.1093\/eurheartj\/eht246","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: pathogenesis and clinical relevance","volume":"11","author":"Wiese S","year":"2014","unstructured":"Wiese S, Hove JD, Bendtsen F, M\u00f8ller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014, 11:177-186. 10.1038\/nrgastro.2013.210","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/BF00496571","article-title":"The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases","volume":"397","author":"Factor SM","year":"1982","unstructured":"Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases. Virchows Arch A Pathol Anat Histol. 1982, 397:301-311. 10.1007\/BF00496571","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong F","year":"2009","unstructured":"Wong F. Cirrhotic cardiomyopathy. Hepatol Int. 2009, 3:294-304. 10.1007\/s12072-008-9109-7","journal-title":"Hepatol Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.075","article-title":"Cirrhotic cardiomyopathy","volume":"56","author":"Zardi EM","year":"2010","unstructured":"Zardi EM, Abbate A, Zardi DM, et al.. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010, 56:539-549. 10.1016\/j.jacc.2009.12.075","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i4.662","article-title":"Arrhythmia risk in liver cirrhosis","volume":"7","author":"Mozos I","year":"2015","unstructured":"Mozos I. Arrhythmia risk in liver cirrhosis. World J Hepatol. 2015, 7:662-672. 10.4254\/wjh.v7.i4.662","journal-title":"World J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong F","year":"2001","unstructured":"Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001, 49:268-275. 10.1136\/gut.49.2.268","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00501.2009","article-title":"Impaired cardiovascular function in primary biliary cirrhosis","volume":"298","author":"Jones DE","year":"2010","unstructured":"Jones DE, Hollingsworth K, Fattakhova G, MacGowan G, Taylor R, Blamire A, Newton JL. Impaired cardiovascular function in primary biliary cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2010, 298:G764-G773. 10.1152\/ajpgi.00501.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260507","article-title":"Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites","volume":"26","author":"Pozzi M","year":"1997","unstructured":"Pozzi M, Carugo S, Boari G, et al.. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997, 26:1131-1137. 10.1002\/hep.510260507","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v6.i7.504","article-title":"Clinical outcomes of compensated and decompensated cirrhosis: a long-term study","volume":"6","author":"Samonakis DN","year":"2014","unstructured":"Samonakis DN, Koulentaki M, Coucoutsi C, et al.. Clinical outcomes of compensated and decompensated cirrhosis: a long-term study. World J Hepatol. 2014, 6:504-512. 10.4254\/wjh.v6.i7.504","journal-title":"World J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.116665","article-title":"Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats","volume":"321","author":"Bolognesi M","year":"2007","unstructured":"Bolognesi M, Sacerdoti D, Piva A, et al.. Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther. 2007, 321:187-194. 10.1124\/jpet.106.116665","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000462974","article-title":"Molecular mechanisms leading to splanchnic vasodilation in liver cirrhosis","volume":"54","author":"Di Pascoli M","year":"2017","unstructured":"Di Pascoli M, Sacerdoti D, Pontisso P, Angeli P, Bolognesi M. Molecular mechanisms leading to splanchnic vasodilation in liver cirrhosis. J Vasc Res. 2017, 54:92-99. 10.1159\/000462974","journal-title":"J Vasc Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01163.x","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman W","year":"2005","unstructured":"Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int. 2005, 25:1079-1090. 10.1111\/j.1478-3231.2005.01163.x","journal-title":"Liver Int"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"M\u00f8ller S","year":"2002","unstructured":"M\u00f8ller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002, 87:9-15. 10.1136\/heart.87.1.9","journal-title":"Heart"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi M","year":"2018","unstructured":"Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018, 15:753-764. 10.1038\/s41575-018-0045-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01227.2006","article-title":"Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems","volume":"292","author":"M\u00f8ller S","year":"2007","unstructured":"M\u00f8ller S, Iversen JS, Henriksen JH, Bendtsen F. Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. Am J Physiol Heart Circ Physiol. 2007, 292:H2966-H2972. 10.1152\/ajpheart.01227.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.03.032","article-title":"The cardiorenal link in advanced cirrhosis","volume":"79","author":"Krag A","year":"2012","unstructured":"Krag A, Bendtsen F, Burroughs AK, M\u00f8ller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012, 79:53-55. 10.1016\/j.mehy.2012.03.032","journal-title":"Med Hypotheses"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"85","author":"M\u00f8ller S","year":"2009","unstructured":"M\u00f8ller S, Henriksen JH. Cardiovascular complications of cirrhosis. Postgrad Med J. 2009, 85:44-54. 10.1136\/gut.2006.112177","journal-title":"Postgrad Med J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec's cirrhosis","volume":"32","author":"Kowalski HJ","year":"1953","unstructured":"Kowalski HJ, Abelman WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest. 1953, 32:1025-1033. 10.1172\/JCI102813","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.003","article-title":"Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis","volume":"65","author":"Sol\u00e0 E","year":"2016","unstructured":"Sol\u00e0 E, Kerbert AJ, Verspaget HW, et al.. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis. J Hepatol. 2016, 65:914-920. 10.1016\/j.jhep.2016.07.003","journal-title":"J Hepatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.02.007","article-title":"Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango","volume":"68","author":"Coenraad MJ","year":"2018","unstructured":"Coenraad MJ, Porcher R, Bendtsen F. Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango. J Hepatol. 2018, 68:887-889. 10.1016\/j.jhep.2018.02.007","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2693-y","article-title":"Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia","volume":"58","author":"Karagiannakis DS","year":"2013","unstructured":"Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci. 2013, 58:3029-3036. 10.1007\/s10620-013-2693-y","journal-title":"Dig Dis Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190509084519","article-title":"Cirrhotic cardiomyopathy: the interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased?","volume":"17","author":"Dourakis SP","year":"2021","unstructured":"Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic cardiomyopathy: the interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased?. Curr Cardiol Rev. 2021, 17:78-84. 10.2174\/1573403X15666190509084519","journal-title":"Curr Cardiol Rev"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/1053-0770(93)90091-x","article-title":"Congestive heart failure: systolic and diastolic function","volume":"7","author":"Little WC","year":"1993","unstructured":"Little WC, Applegate RJ. Congestive heart failure: systolic and diastolic function. J Cardiothorac Vasc Anesth. 1993, 7:2-5. 10.1016\/1053-0770(93)90091-x","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy M","year":"2020","unstructured":"Izzy M, VanWagner LB, Lin G, et al.. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology. 2020, 71:334-345. 10.1002\/hep.30875","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","author":"Krag A","year":"2010","unstructured":"Krag A, Bendtsen F, Mortensen C, Henriksen JH, M\u00f8ller S. Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol. 2010, 22:1085-1092. 10.1097\/MEG.0b013e32833a4822","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.49.4.755","article-title":"Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain","volume":"49","author":"Limas CJ","year":"1974","unstructured":"Limas CJ, Guiha NH, Lekagul O, Cohn JN. Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. Circulation. 1974, 49:754-760. 10.1161\/01.cir.49.4.755","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500040513","article-title":"Post-liver transplantation myocardial dysfunction","volume":"4","author":"Sampathkumar P","year":"1998","unstructured":"Sampathkumar P, Lerman A, Kim BY, Narr BJ, Poterucha JJ, Torsher LC, Plevak DJ. Post-liver transplantation myocardial dysfunction. Liver Transpl Surg. 1998, 4:399-403. 10.1002\/lt.500040513","journal-title":"Liver Transpl Surg"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(86)91556-4","article-title":"Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites","volume":"1","author":"Gerbes AL","year":"1986","unstructured":"Gerbes AL, Remien J, J\u00fcngst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet. 1986, 1:1409-1411. 10.1016\/s0140-6736(86)91556-4","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.4.11.2165947","article-title":"Turning off the signal: desensitization of beta-adrenergic receptor function","volume":"4","author":"Hausdorff WP","year":"1990","unstructured":"Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 1990, 4:2881-2889.","journal-title":"FASEB J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120306","article-title":"Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats","volume":"12","author":"Lee SS","year":"1990","unstructured":"Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990, 12:481-485. 10.1002\/hep.1840120306","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(00)70180-6","article-title":"Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"118","author":"Liu H","year":"2000","unstructured":"Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology. 2000, 118:937-944. 10.1016\/s0016-5085(00)70180-6","journal-title":"Gastroenterology"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000194329.41863.89","article-title":"Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure","volume":"97","author":"Ai X","year":"2005","unstructured":"Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005, 97:1314-1322. 10.1161\/01.RES.0000194329.41863.89","journal-title":"Circ Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2001.280.1.G68","article-title":"Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat","volume":"280","author":"Liu H","year":"2001","unstructured":"Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol. 2001, 280:G68-G74. 10.1152\/ajpgi.2001.280.1.G68","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706331","article-title":"Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"146","author":"Gaskari SA","year":"2005","unstructured":"Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005, 146:315-323. 10.1038\/sj.bjp.0706331","journal-title":"Br J Pharmacol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.84.3.253","article-title":"Nitric oxide as a bifunctional regulator of apoptosis","volume":"84","author":"Kim YM","year":"1999","unstructured":"Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 1999, 84:253-256. 10.1161\/01.res.84.3.253","journal-title":"Circ Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai EJ","year":"2009","unstructured":"Tsai EJ, Kass DA. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther. 2009, 122:216-238. 10.1016\/j.pharmthera.2009.02.009","journal-title":"Pharmacol Ther"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1042\/CS20010154","article-title":"Nitric oxide and renal and cardiac dysfunction in cirrhosis","volume":"102","author":"Garc\u00eda-Esta\u00f1 J","year":"2002","unstructured":"Garc\u00eda-Esta\u00f1 J, Ortiz MC, Lee SS. Nitric oxide and renal and cardiac dysfunction in cirrhosis. Clin Sci (Lond). 2002, 102:213-222.","journal-title":"Clin Sci (Lond)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1152\/nips.01386.2002","article-title":"Cholinergic control of heart rate by nitric oxide is site specific","volume":"17","author":"Herring N","year":"2002","unstructured":"Herring N, Danson EJ, Paterson DJ. Cholinergic control of heart rate by nitric oxide is site specific. News Physiol Sci. 2002, 17:202-206. 10.1152\/nips.01386.2002","journal-title":"News Physiol Sci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(96)80272-8","article-title":"Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related","volume":"24","author":"van Obbergh L","year":"1996","unstructured":"van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol. 1996, 24:747-752. 10.1016\/s0168-8278(96)80272-8","journal-title":"J Hepatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705666","article-title":"The endocannabinoid system: a general view and latest additions","volume":"141","author":"De Petrocellis L","year":"2004","unstructured":"De Petrocellis L, Cascio MG, Di Marzo V. The endocannabinoid system: a general view and latest additions. Br J Pharmacol. 2004, 141:765-774. 10.1038\/sj.bjp.0705666","journal-title":"Br J Pharmacol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12263","article-title":"The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives","volume":"33","author":"Baldassarre M","year":"2013","unstructured":"Baldassarre M, Giannone FA, Napoli L, Tovoli A, Ricci CS, Tufoni M, Caraceni P. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. Liver Int. 2013, 33:1298-1308. 10.1111\/liv.12263","journal-title":"Liver Int"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids","volume":"53","author":"Yang YY","year":"2010","unstructured":"Yang YY, Liu H, Nam SW, Kunos G, Lee SS. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. J Hepatol. 2010, 53:298-306. 10.1016\/j.jhep.2010.03.011","journal-title":"J Hepatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130642","article-title":"Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice","volume":"127","author":"Nam SW","year":"2014","unstructured":"Nam SW, Liu H, Wong JZ, Feng AY, Chu G, Merchant N, Lee SS. Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice. Clin Sci (Lond). 2014, 127:519-526. 10.1042\/CS20130642","journal-title":"Clin Sci (Lond)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2005.01.012","article-title":"Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction","volume":"38","author":"Ren J","year":"2005","unstructured":"Ren J, Zhang S, Kovacs A, Wang Y, Muslin AJ. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol. 2005, 38:617-623. 10.1016\/j.yjmcc.2005.01.012","journal-title":"J Mol Cell Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000189270.72915.D1","article-title":"Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes","volume":"97","author":"Chen X","year":"2005","unstructured":"Chen X, Zhang X, Kubo H, et al.. Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res. 2005, 97:1009-1017. 10.1161\/01.RES.0000189270.72915.D1","journal-title":"Circ Res"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/345618a0","article-title":"Kinetics, stoichiometry and role of the Na-Ca exchange mechanism in isolated cardiac myocytes","volume":"345","author":"Crespo LM","year":"1990","unstructured":"Crespo LM, Grantham CJ, Cannell MB. Kinetics, stoichiometry and role of the Na-Ca exchange mechanism in isolated cardiac myocytes. Nature. 1990, 345:618-621. 10.1038\/345618a0","journal-title":"Nature"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1159\/000492791","article-title":"Hepatorenal syndrome or hepatocardiorenal syndrome: revisiting basic concepts in view of emerging data","volume":"9","author":"Kazory A","year":"2019","unstructured":"Kazory A, Ronco C. Hepatorenal syndrome or hepatocardiorenal syndrome: revisiting basic concepts in view of emerging data. Cardiorenal Med. 2019, 9:1-7. 10.1159\/000492791","journal-title":"Cardiorenal Med"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto DA","year":"2020","unstructured":"Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ. 2020, 370:m2687. 10.1136\/bmj.m2687","journal-title":"BMJ"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol L","year":"2005","unstructured":"Ruiz-del-Arbol L, Monescillo A, Arocena C, et al.. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005, 42:439-447. 10.1002\/hep.20766","journal-title":"Hepatology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1159\/000349969","article-title":"Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Haase M","year":"2013","unstructured":"Haase M, M\u00fcller C, Damman K, Murray PT, Kellum JA, Ronco C, McCullough PA. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013, 182:99-116. 10.1159\/000349969","journal-title":"Contrib Nephrol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.029413","article-title":"Assessment of diastolic function: what the general cardiologist needs to know","volume":"91","author":"Mottram PM","year":"2005","unstructured":"Mottram PM, Marwick TH. Assessment of diastolic function: what the general cardiologist needs to know. Heart. 2005, 91:681-695. 10.1136\/hrt.2003.029413","journal-title":"Heart"},{"key":"ref74","article-title":"Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats","volume":"273","author":"Kim S","year":"1995","unstructured":"Kim S, Ohta K, Hamaguchi A, et al.. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther. 1995, 273:509-515.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.5.7529","article-title":"Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy","volume":"141","author":"Takeda Y","year":"2000","unstructured":"Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology. 2000, 141:1901-1904. 10.1210\/endo.141.5.7529","journal-title":"Endocrinology"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.030","article-title":"Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats","volume":"55","author":"Glenn TK","year":"2011","unstructured":"Glenn TK, Honar H, Liu H, ter Keurs HE, Lee SS. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol. 2011, 55:1249-1255. 10.1016\/j.jhep.2011.02.030","journal-title":"J Hepatol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.5.743","article-title":"Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt","volume":"44","author":"Huonker M","year":"1999","unstructured":"Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, R\u00f6ssle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut. 1999, 44:743-748. 10.1136\/gut.44.5.743","journal-title":"Gut"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(03)00057-6","article-title":"Qt interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt","volume":"38","author":"Trevisani F","year":"2003","unstructured":"Trevisani F, Merli M, Savelli F, et al.. Qt interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003, 38:461-467. 10.1016\/s0168-8278(03)00057-6","journal-title":"J Hepatol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1997.273.2.G537","article-title":"Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis","volume":"273","author":"Ward CA","year":"1997","unstructured":"Ward CA, Ma Z, Lee SS, Giles WR. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol. 1997, 273:G537-G544. 10.1152\/ajpgi.1997.273.2.G537","journal-title":"Am J Physiol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1113\/JP272864","article-title":"Potassium channels in the heart: structure, function and regulation","volume":"595","author":"Grandi E","year":"2017","unstructured":"Grandi E, Sanguinetti MC, Bartos DC, et al.. Potassium channels in the heart: structure, function and regulation. J Physiol. 2017, 595:2209-2228. 10.1113\/JP272864","journal-title":"J Physiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.76.5.790","article-title":"Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements","volume":"76","author":"Bouchard RA","year":"1995","unstructured":"Bouchard RA, Clark RB, Giles WR. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements. Circ Res. 1995, 76:790-801. 10.1161\/01.res.76.5.790","journal-title":"Circ Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1994.267.1.G87","article-title":"Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats","volume":"267","author":"Ma Z","year":"1994","unstructured":"Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats. Am J Physiol. 1994, 267:G87-G93. 10.1152\/ajpgi.1994.267.1.G87","journal-title":"Am J Physiol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(02)00010-7","article-title":"Dyssynchronous electrical and mechanical systole in patients with cirrhosis","volume":"36","author":"Henriksen JH","year":"2002","unstructured":"Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, M\u00f8ller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol. 2002, 36:513-520. 10.1016\/s0168-8278(02)00010-7","journal-title":"J Hepatol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2012.02847.x","article-title":"QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis","volume":"32","author":"Trevisani F","year":"2012","unstructured":"Trevisani F, Di Micoli A, Zambruni A, et al.. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int. 2012, 32:1510-1515. 10.1111\/j.1478-3231.2012.02847.x","journal-title":"Liver Int"},{"key":"ref85","article-title":"Drug-induced QT prolongation and sudden death","volume":"107","author":"Del Rosario ME","year":"2010","unstructured":"Del Rosario ME, Weachter R, Flaker GC. Drug-induced QT prolongation and sudden death . Mo Med. 2010, 107:53-58.","journal-title":"Mo Med"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270106","article-title":"Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors","volume":"27","author":"Bernardi M","year":"1998","unstructured":"Bernardi M, Calandra S, Colantoni A, et al.. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology. 1998, 27:28-34. 10.1002\/hep.510270106","journal-title":"Hepatology"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2003.00833.x","article-title":"Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation","volume":"23","author":"Bal JS","year":"2003","unstructured":"Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int. 2003, 23:243-248. 10.1034\/j.1600-0676.2003.00833.x","journal-title":"Liver Int"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1247621","article-title":"Unexpected complication following esophageal variceal hemorrhage - case 2\/2011","volume":"136","author":"Werner CR","year":"2011","unstructured":"Werner CR, Riessen R, Gregor M, Bitzer M. Unexpected complication following esophageal variceal hemorrhage - case 2\/2011. Dtsch Med Wochenschr. 2011, 136:217. 10.1055\/s-0030-1247621","journal-title":"Dtsch Med Wochenschr"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1313182","article-title":"Frequency of cardiac arrhythmia in patients with liver cirrhoses and evaluation of associated factors","volume":"50","author":"Gundling F","year":"2012","unstructured":"Gundling F, Schmidtler F, Zelihic E, et al.. Frequency of cardiac arrhythmia in patients with liver cirrhoses and evaluation of associated factors. Z Gastroenterol. 2012, 50:1149-1155. 10.1055\/s-0032-1313182","journal-title":"Z Gastroenterol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90940-d","article-title":"Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis","volume":"12","author":"Bernardi M","year":"1999","unstructured":"Bernardi M, Rubboli A, Trevisani F, et al.. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. JHepatol. 1999, 12:207-216. 10.1016\/0168-8278(91)90940-d","journal-title":"JHepatol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.12.001","article-title":"Beta-blockers in cirrhosis: evidence-based indications\u00a0and\u00a0limitations","volume":"2","author":"Rodrigues SG","year":"2020","unstructured":"Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications\u00a0and\u00a0limitations. JHEP Rep. 2020, 2:100063. 10.1016\/j.jhepr.2019.12.001","journal-title":"JHEP Rep"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X12666161028122649","article-title":"Strain imaging echocardiography: what imaging cardiologists should know","volume":"13","author":"Lopez-Candales A","year":"2017","unstructured":"Lopez-Candales A, Hernandez-Suarez DF. Strain imaging echocardiography: what imaging cardiologists should know. Curr Cardiol Rev. 2017, 13:118-129. 10.2174\/1573403X12666161028122649","journal-title":"Curr Cardiol Rev"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.01.031","article-title":"Two-dimensional global longitudinal strain is superior to left ventricular ejection fraction in prediction of outcome in patients with left-sided infective endocarditis","volume":"260","author":"Lauridsen TK","year":"2018","unstructured":"Lauridsen TK, Alhede C, Crowley AL, et al.. Two-dimensional global longitudinal strain is superior to left ventricular ejection fraction in prediction of outcome in patients with left-sided infective endocarditis. Int J Cardiol. 2018, 260:118-123. 10.1016\/j.ijcard.2018.01.031","journal-title":"Int J Cardiol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)90416-0","article-title":"Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and doppler echocardiographic study","volume":"12","author":"Appleton CP","year":"1988","unstructured":"Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and doppler echocardiographic study. J Am Coll Cardiol. 1988, 12:426-440. 10.1016\/0735-1097(88)90416-0","journal-title":"J Am Coll Cardiol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh SF","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009, 22:107-133. 10.1016\/j.echo.2008.11.023","journal-title":"J Am Soc Echocardiogr"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.2174\/187152907780059074","article-title":"Potential therapeutic targets in cirrhotic cardiomyopathy","volume":"7","author":"Pozzi M","year":"2007","unstructured":"Pozzi M, Ratti L, Guidi C, Milanese M, Mancia G. Potential therapeutic targets in cirrhotic cardiomyopathy. Cardiovasc Hematol Disord Drug Targets. 2007, 7:21-26. 10.2174\/187152907780059074","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26288","article-title":"Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis","volume":"121","author":"Gonz\u00e1lez-Abraldes J","year":"2001","unstructured":"Gonz\u00e1lez-Abraldes J, Albillos A, Ba\u00f1ares R, et al.. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2001, 121:382-388. 10.1053\/gast.2001.26288","journal-title":"Gastroenterology"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.10.026","article-title":"Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis","volume":"40","author":"Henriksen JH","year":"2004","unstructured":"Henriksen JH, Bendtsen F, Hansen EF, M\u00f8ller S. Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol. 2004, 40:239-246. 10.1016\/j.jhep.2003.10.026","journal-title":"J Hepatol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9 T","year":"2010","unstructured":"Serst\u00e9 T, Melot C, Francoz C, et al.. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010, 52:1017-1022. 10.1002\/hep.23775","journal-title":"Hepatology"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa M","year":"2005","unstructured":"Torregrosa M, Aguad\u00e9 S, Dos L, et al.. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005, 42:68-74. 10.1016\/j.jhep.2004.09.008","journal-title":"J Hepatol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2097","article-title":"Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation","volume":"15","author":"Renga B","year":"2009","unstructured":"Renga B, Mencarelli A, Migliorati M, Distrutti E, Fiorucci S. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World J Gastroenterol. 2009, 15:2097-2108. 10.3748\/wjg.15.2097","journal-title":"World J Gastroenterol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151136298","article-title":"NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension","volume":"98","author":"Fiorucci S","year":"2001","unstructured":"Fiorucci S, Antonelli E, Morelli O, et al.. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A. 2001, 98:8897-8902. 10.1073\/pnas.151136298","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107949-cirrhotic-cardiomyopathy-the-interplay-between-liver-and-heart","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:11Z","timestamp":1707508091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107949-cirrhotic-cardiomyopathy-the-interplay-between-liver-and-heart"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":102,"URL":"https:\/\/doi.org\/10.7759\/cureus.27969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,13]]}}}